Europe Under Pressure with Rising Covid Cases, UK GDP Growth Slowing in September
Fiona Cincotta November 12, 2020 6:42 PM
Covid cases across Europe continue to rise putting the covid trade back into play. UK GDP rebounded at a record rate, but less than forecast.
European bourses are heading lower on the open as vaccine optimism which has driven the rally across the first part of the week fizzles and the covid trade is back in play. Weaker than forecast UK GDP adds to the downbeat mood.
UK GDP data revealed that the UK economy staged a record recovery in the third quarter surging 15.5% in the July to September period. This came after a record -19.8% GDP collapse in Q2 during the lockdown period. As the economy reopened, businesses flung open their doors and the economy rebounded, although it did so a slightly weaker rate than the 15.8% expected.
Whilst the economy has grown for an impressive 5 straight months, it is still -8.2% smaller than in February.
Slowing growth in September
The MoM September GDP sheds more light on the picture, increasing 1.1%, down from 2.2% in August and also short of the 1.5% expected. This shows us that the UK economy was starting to slow even before lockdown 2.0 as pent up demand eased and the Chancellor’s Eat Out to Help Out scheme came to an end.
Between record redundancies and signs of growth slowing in September, the outlook for the UK economy was showing signs of weakness even before lockdown 2.0 came into play. This most doesn’t bode well for the coming months as conditions deteriorate further.
GBP/USD is trading -0.3% lower only extending losses slighty following the data. FTSE futures are pointing to losses 0.7% on the open.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.